Trial Profile
A phase II study of fludarabine, cyclophosphamide and rituximab as therapy in chronic lymphocytic leukaemia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2005
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 28 Nov 2005 New trial record.